Human Membranous Nephropathy Peripheral Blood Mononuclear Cells

Description

Human Membranous Nephropathy Peripheral Blood Mononuclear Cells (PBMCs) are derived from peripheral blood of patients diagnosed with membranous nephropathy (MN), an autoimmune kidney disorder characterized by immune complex deposition in the glomerulus. These cells contain key immunological components, including lymphocytes and monocytes, which are central to investigating autoimmune mechanisms, immune dysregulation, and antibody production related to MN pathogenesis. Widely utilized in research for identifying novel biomarkers, studying disease-specific immune responses, and evaluating therapeutic strategies, these PBMCs provide valuable insight into the immunological basis of membranous nephropathy.

Application

• For research use only.

• Human Membranous Nephropathy PBMCs are crucial for autoimmune and renal disease research, particularly in investigating immunopathogenesis, autoantibody production, inflammatory cytokine profiles, and cellular immune responses involved in disease progression. They facilitate biomarker discovery, drug screening, evaluation of immunosuppressive therapies, and development of personalized treatment approaches for membranous nephropathy and other immune-mediated kidney disorders.